Literature DB >> 24037748

Cohort study of cases with prolonged tracheal extubation times to examine the relationship with duration of workday.

Richard H Epstein1, Franklin Dexter, Sorin J Brull.   

Abstract

PURPOSE: The economics of the use of an anesthetic drug or device that produces benefit through reduction in operating room (OR) time depends on the day of the week and the total hours of surgical cases in the OR in which they are performed. Principally, this has to do with different durations of the regularly scheduled workday in the ORs within and among hospitals. We tested hypotheses relevant to the economic benefit of avoiding prolonged tracheal extubation times.
METHODS: Observational data were obtained from a multiple-specialty academic tertiary hospital that uses an anesthesia information management system. Prolonged tracheal extubation times were considered those with tracheal extubations occurring 15 min or more after the end of surgery. The assessment of prolonged tracheal extubation times was limited to cases for which the patient's trachea was intubated and extubated while physically in the OR. Percentages were calculated for each of n = 39 four-week periods. Results are reported as mean (standard error of the mean) of these percentages, and the phrases "at most/least" are used to refer to the corresponding 95% confidence limits.
RESULTS: At most, 6.1% [mean 5.5 (0.3)%] of the prolonged tracheal extubation times were attributable to cases that did not end during regular workdays from 7:00 AM-10:59 PM. At least 55.6% of prolonged tracheal extubation times occurred during cases on regular workdays and in an OR with more than eight hours of cases and turnovers [mean 57.0 (0.9)%; P < 0.0001]. This percentage was 23.8 (0.8)% larger than for all other cases.
CONCLUSIONS: In the absence of an accurate facility-specific cost analysis, prolonged tracheal extubation times should not be treated as fixed costs but as resulting in proportionally increased OR variable costs.

Entities:  

Mesh:

Year:  2013        PMID: 24037748     DOI: 10.1007/s12630-013-0025-5

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  6 in total

1.  Analyses of Time to Recovery Including Time to Tracheal Extubation Need to Be Performed While Incorporating Their Probability Distribution.

Authors:  Franklin Dexter; Richard H Epstein
Journal:  Obes Surg       Date:  2018-01       Impact factor: 4.129

2.  Comparison of Anesthesia-Controlled Operating Room Time between Propofol-Based Total Intravenous Anesthesia and Desflurane Anesthesia in Open Colorectal Surgery: A Retrospective Study.

Authors:  Wei-Hung Chan; Meei-Shyuan Lee; Chin Lin; Chang-Chieh Wu; Hou-Chuan Lai; Shun-Ming Chan; Chueng-He Lu; Chen-Hwan Cherng; Zhi-Fu Wu
Journal:  PLoS One       Date:  2016-10-25       Impact factor: 3.240

3.  Planning for operating room efficiency and faster anesthesia wake-up time in open major upper abdominal surgery.

Authors:  Hou-Chuan Lai; Shun-Ming Chan; Chueng-He Lu; Chih-Shung Wong; Chen-Hwan Cherng; Zhi-Fu Wu
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

4.  Appropriate dosing of sugammadex for reversal of rocuronium-/vecuronium-induced muscle relaxation in morbidly obese patients: a meta-analysis of randomized controlled trials.

Authors:  Jian-Qiang Liao; Darrell Shih; Tzu-Yu Lin; Meng Lee; Cheng-Wei Lu
Journal:  J Int Med Res       Date:  2022-08       Impact factor: 1.573

5.  Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center.

Authors:  Michele Carron; Fabio Baratto; Francesco Zarantonello; Carlo Ori
Journal:  Clinicoecon Outcomes Res       Date:  2016-02-18

6.  Analysis of anesthesia-controlled operating room time after propofol-based total intravenous anesthesia compared with desflurane anesthesia in functional endoscopic sinus surgery.

Authors:  Tien-Chien Liu; Hou-Chuan Lai; Chueng-He Lu; Yuan-Shiou Huang; Nan-Kai Hung; Chen-Hwan Cherng; Zhi-Fu Wu
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.